fanconi anemia and vaginal squamous cell carcinoma

Clicks: 270
ID: 158582
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #2 of 2 articles by views in revista de urbanismo

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Fanconi Anemia (FA) is an autosomal recessive disease characterized by chromosome instability, cellular hypersensitivity to DNA cross-linking agents, and increased predisposition to malignancies. We describe here a 28 year-old female with FA and vaginal squamous cell carcinoma treated by radiation therapy alone. The patient developed arm phlebitis, pulmonary fungal infection, and severe rectal bleeding, followed by hypocalcaemia, hypokalemia, vaginal bacterial and fungal infection, with subsequent leg and arm phlebitis, perineal abscess, and sepsis. The patient died 12 weeks later.
Reference Key
carvalho2012rarefanconi Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Jesus Paula Carvalho;Edmund Chada Baracat;Maria Del Pilar Esteves Diz;Heloisa de Andrade Carvalho;Filomena Marino de Carvalho;Marcela Cavalcante de Andrade Silva;Altamiro Ribeiro Dias Jr.
Journal revista de urbanismo
Year 2012
DOI
10.4081/rt.2012.e4
URL
http://www.pagepress.org/journals/index.php/rt/article/view/2960
Keywords
fanconi anemia Oncology radiation therapy squamous cell carcinoma including cancer and carcinogens tumors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.